Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-007908
Filing Date
2025-02-21
Accepted
2025-02-21 17:01:58
Documents
75
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2143940
2 ex23-1.htm EX-23.1 3166
3 ex31-1.htm EX-31.1 19374
4 ex31-2.htm EX-31.2 19238
5 ex32-1.htm EX-32.1 5616
6 ex32-2.htm EX-32.2 5680
7 form10-k_001.jpg GRAPHIC 66302
8 form10-k_002.jpg GRAPHIC 79269
9 form10-k_003.jpg GRAPHIC 17189
10 form10-k_004.jpg GRAPHIC 33919
11 form10-k_005.jpg GRAPHIC 52578
12 form10-k_006.jpg GRAPHIC 53141
  Complete submission text file 0001493152-25-007908.txt   8539632

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE gtbp-20241231.xsd EX-101.SCH 43601
14 XBRL CALCULATION FILE gtbp-20241231_cal.xml EX-101.CAL 44358
15 XBRL DEFINITION FILE gtbp-20241231_def.xml EX-101.DEF 190679
16 XBRL LABEL FILE gtbp-20241231_lab.xml EX-101.LAB 417477
17 XBRL PRESENTATION FILE gtbp-20241231_pre.xml EX-101.PRE 330091
77 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1212384
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40023 | Film No.: 25652918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)